DK0527720T3 - Terapeutiske midler - Google Patents

Terapeutiske midler

Info

Publication number
DK0527720T3
DK0527720T3 DK90904349.9T DK90904349T DK0527720T3 DK 0527720 T3 DK0527720 T3 DK 0527720T3 DK 90904349 T DK90904349 T DK 90904349T DK 0527720 T3 DK0527720 T3 DK 0527720T3
Authority
DK
Denmark
Prior art keywords
formula
compound
ace
inhibitor
methyl
Prior art date
Application number
DK90904349.9T
Other languages
English (en)
Inventor
Patrick Coleman Oconnor
Charles Leon-Marie Defesche
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of DK0527720T3 publication Critical patent/DK0527720T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK90904349.9T 1989-03-15 1990-03-12 Terapeutiske midler DK0527720T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32421389A 1989-03-15 1989-03-15

Publications (1)

Publication Number Publication Date
DK0527720T3 true DK0527720T3 (da) 1994-12-05

Family

ID=23262607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90904349.9T DK0527720T3 (da) 1989-03-15 1990-03-12 Terapeutiske midler

Country Status (13)

Country Link
EP (1) EP0527720B1 (da)
JP (1) JPH04503806A (da)
KR (1) KR920700642A (da)
AT (1) ATE109981T1 (da)
AU (1) AU640128B2 (da)
CA (1) CA2049980A1 (da)
DE (1) DE69011692T2 (da)
DK (1) DK0527720T3 (da)
ES (1) ES2057542T3 (da)
IE (1) IE65902B1 (da)
IL (1) IL93744A (da)
WO (1) WO1990010445A1 (da)
ZA (1) ZA901945B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0651640A1 (en) * 1992-07-21 1995-05-10 Knoll AG Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat

Also Published As

Publication number Publication date
IE65902B1 (en) 1995-11-29
CA2049980A1 (en) 1990-09-16
JPH04503806A (ja) 1992-07-09
DE69011692D1 (de) 1994-09-22
IL93744A (en) 1995-06-29
IE900818L (en) 1990-09-15
KR920700642A (ko) 1992-08-10
DE69011692T2 (de) 1994-12-01
IL93744A0 (en) 1990-12-23
AU640128B2 (en) 1993-08-19
ZA901945B (en) 1991-01-30
WO1990010445A1 (en) 1990-09-20
AU5261690A (en) 1990-10-09
EP0527720B1 (en) 1994-08-17
EP0527720A1 (en) 1993-02-24
ATE109981T1 (de) 1994-09-15
ES2057542T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
ES2145913T3 (es) Inhibidores de metaloproteasas.
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
DE69420872D1 (de) Hgh enthaltende pharmazeutische zubereitungen
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
DK0527720T3 (da) Terapeutiske midler
EP0980366A4 (en) ANTITHROMOSIS
MY110416A (en) Composition for the treatment of schizophrenia.